DFFA
Basic information
Region (hg38): 1:10456522-10472529
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (49 variants)
- not_provided (5 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DFFA gene is commonly pathogenic or not. These statistics are base on transcript: NM_000004401.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | |||||
| missense | 44 | 53 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 44 | 6 | 4 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| DFFA | protein_coding | protein_coding | ENST00000377038 | 6 | 16005 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.0000866 | 0.793 | 125626 | 0 | 121 | 125747 | 0.000481 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.322 | 176 | 188 | 0.934 | 0.0000101 | 2134 |
| Missense in Polyphen | 45 | 57.2 | 0.78671 | 734 | ||
| Synonymous | 0.933 | 71 | 81.7 | 0.869 | 0.00000443 | 680 |
| Loss of Function | 1.17 | 8 | 12.4 | 0.643 | 5.27e-7 | 146 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000452 | 0.000452 |
| Ashkenazi Jewish | 0.00606 | 0.00607 |
| East Asian | 0.00109 | 0.00109 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.000212 | 0.000211 |
| Middle Eastern | 0.00109 | 0.00109 |
| South Asian | 0.000163 | 0.000163 |
| Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Inhibitor of the caspase-activated DNase (DFF40).;
- Pathway
- Apoptosis - Homo sapiens (human);Apoptosis Modulation and Signaling;Apoptosis;Fas Ligand (FasL) pathway and Stress induction of Heat Shock Proteins (HSP) regulation;Apoptotic Signaling Pathway;caspase cascade in apoptosis;granzyme a mediated apoptosis pathway;induction of apoptosis through dr3 and dr4/5 death receptors;hiv-1 nef: negative effector of fas and tnf;apoptotic dna-fragmentation and tissue homeostasis;Activation of DNA fragmentation factor;Apoptosis induced DNA fragmentation;Apoptotic execution phase;Apoptosis;Programmed Cell Death;Caspase Cascade in Apoptosis;HIV-1 Nef: Negative effector of Fas and TNF-alpha
(Consensus)
Recessive Scores
- pRec
- 0.127
Intolerance Scores
- loftool
- 0.148
- rvis_EVS
- 0.51
- rvis_percentile_EVS
- 80.1
Haploinsufficiency Scores
- pHI
- 0.257
- hipred
- N
- hipred_score
- 0.457
- ghis
- 0.486
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0000508
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dffa
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); cellular phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- apoptotic DNA fragmentation;negative regulation of deoxyribonuclease activity;positive regulation of apoptotic process;chaperone-mediated protein folding;thymocyte apoptotic process;negative regulation of execution phase of apoptosis;negative regulation of apoptotic DNA fragmentation
- Cellular component
- nuclear chromatin;nucleus;nucleoplasm;lipid droplet;cytosol;plasma membrane
- Molecular function
- protein binding;protein domain specific binding;protein folding chaperone;deoxyribonuclease inhibitor activity